Y-90 Radioembolization for the Treatment of Metastatic Colorectal Cancer – Does Primary Tumor Location Prognosticate Survival?

Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.20.25315

Giuseppe V. Toia, MD reviews a retrospective study exploring prognostic factors for patients with chemorefractory metastatic colorectal cancer treated with Y-90 radioembolization. The study emphasizes primary tumor location as a predictor of overall survival.